RxDoctor Payments Data

Thomas Mazzoni, DO

Otolaryngology/Facial Plastic Surgery · Iselin, NJNPI 1629192463

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,814 of the $9,175 with a category attached, or 85.2%. 26 manufacturers reported payments, led by Aerin Medical Inc. at 42.9% of the total. Among otolaryngology/facial plastic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,175in general payments, 2019–2025

Across 246 payments — averaging $37.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$4K
  • Inspire Medical Systems, Inc.$2K
  • Sanofi$683
  • Regeneron Healthcare Solutions, Inc.$485
  • Optinose US, Inc.$473
  • GSK$343
  • plus $1K from 20 others

What the payments were for

  • Travel & lodging$1,30814%
  • Food & beverage$7,81485%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,175 in reported general payments places this provider in the 90th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.

See all otolaryngology/facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$206,700
Medicare patients
562
Services billed
1,611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate204$2,517
Ipratropium Bromide116$2,303
Tobramycin-DexamethasoneTobramycin/Dexamethasone29$2,256
Fluocinolone Acetonide Oil34$1,433
Levocetirizine Dihydrochloride84$1,402
CefuroximeCefuroxime Axetil73$1,249
Ofloxacin32$1,147
Azelastine Hcl32$614
Omeprazole49$581
Famotidine18$251
Methylprednisolone45$243
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$212
Montelukast Sodium29$137
Mupirocin21$126
Prednisone45$97

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Iselin

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →